David T Hagerty Insider Trading
Get free email notifications about insider trading for David T Hagerty.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David T Hagerty. David T Hagerty is a Senior VP & CMO in Ardea Biosciences, Inc./DE ($IBPI) and a EVP, Clinical Development in Conatus Pharmaceuticals Inc. ($CNAT).
Address: 4939 DIRECTORS PLACE SAN DIEGO 92121 CA
Companies in which David T Hagerty is an Insider
Ardea Biosciences, Inc./DE
Trading Symbol: IBPIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David T Hagerty: Senior VP & CMO
Holdings: 0 shares
Latest Transaction: Jun 20 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Histogen Inc.
Trading Symbol: HSTOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David T Hagerty: EVP, Clinical Development
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 11 2019
$HSTO Market Capitalization: $127.38M
$HSTO Previous Close: $5.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of David T Hagerty
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 11 2019 | CNAT | Conatus Pharmaceut ... | Hagerty David T | EVP, Clinical Devel ... | Option Exercise | A | 2.00 | 175,000 | 350,000 | 175,000 | |
Feb 05 2018 | CNAT | Conatus Pharmaceut ... | Hagerty David T | EVP, Clinical Devel ... | Option Exercise | A | 5.17 | 70,000 | 361,900 | 70,000 | |
Feb 01 2017 | CNAT | Conatus Pharmaceut ... | Hagerty David T | EVP, Clinical Devel ... | Option Exercise | A | 4.21 | 100,625 | 423,631 | 100,625 | |
Feb 08 2016 | CNAT | Conatus Pharmaceut ... | Hagerty David T | EVP, Clinical Devel ... | Option Exercise | A | 1.85 | 21,875 | 40,469 | 21,875 | |
Feb 08 2016 | CNAT | Conatus Pharmaceut ... | Hagerty David T | EVP, Clinical Devel ... | Option Exercise | A | 1.85 | 109,375 | 202,344 | 109,375 | |
Jun 20 2012 | IBPI | Ardea Biosciences, ... | Hagerty David T | Senior VP & CMO | Option Exercise | D | 18.94 | 33,600 | 636,384 | 0 | |
Jun 20 2012 | IBPI | Ardea Biosciences, ... | Hagerty David T | Senior VP & CMO | Option Exercise | D | 26.00 | 134,616 | 3,500,016 | 0 |